Cadila Healthcare intimates successful completion of inspection of Changodar facility
By USFDA
Cadila Healthcare announced that USFDA inspected its Topical manufacturing facility at Changodar, near Ahmedabad, from 03 April to 07 April 2017. At the end of the inspection, no observation (483) is issued. The Company has filed 17 products with the USFDA from this manufacturing facility.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 07 2017 | 7:53 PM IST